ZBNA
AXSM icon

Zions Bancorporation, National Association’s Axsome Therapeutics AXSM Stock Holding History

Zions Bancorporation, National Association’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.67K Buy
15
+9
+150% +$1.95K ﹤0.01% 1156
2026
Q1 		$1.01K Buy
+6
New +$1.04K ﹤0.01% 1349

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Zions Bancorporation, National Association's AXSM Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Axsome Therapeutics (AXSM) stake by 150% in Q2 2026, buying an estimated $1.95K and bringing the position to 15 shares worth $3.67K. The position accounts for ﹤0.01% of the portfolio, ranked #1156.

Zions Bancorporation, National Association first reported a position in AXSM in Q1 2026 and has held it in 2 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Zions Bancorporation, National Association held 15 shares of Axsome Therapeutics worth $3.67K as of Q2 2026.
  • Zions Bancorporation, National Association bought 9 Axsome Therapeutics shares in Q2 2026, an estimated $1.95K.
  • Axsome Therapeutics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1156 holding.
  • Zions Bancorporation, National Association first reported a position in Axsome Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.